Global Molecular Glue Degrader Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Molecular Glue Degrader Market Research Report 2024
In particular, molecular glue degraders are monovalent compounds that orchestrate interactions between a target protein and an E3 ubiquitin ligase, prompting the proteasomal degradation of the former.
According to QYResearch’s new survey, global Molecular Glue Degrader market is projected to reach US$ 649.6 million in 2034, increasing from US$ 365 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Molecular Glue Degrader market research.
Key manufacturers engaged in the Molecular Glue Degrader industry include Proxygen GmbH, BeyondSpring, Life Sensors, Evotec SE, Eli Lilly and Company, Bristol-Myers Squibb Company, C4 Therapeutics, Incyte and Monte Rosa Therapeutics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Molecular Glue Degrader were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Molecular Glue Degrader market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Molecular Glue Degrader market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Proxygen GmbH
BeyondSpring
Life Sensors
Evotec SE
Eli Lilly and Company
Bristol-Myers Squibb Company
C4 Therapeutics
Incyte
Monte Rosa Therapeutics
Segment by Type
Proteolysis Targeting Chimeras (Protags)
Specific and Non-Genetic IAP-Dependent Protein Erasers (Snipers) Target Oriented Protein Degrader Optimizer (TORPEDO)
Lysosomal Targeting Chimeras (Lyttas)
Others
Cancer Treatment
Infectious Diseases
Genetic Diseases
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Molecular Glue Degrader report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to QYResearch’s new survey, global Molecular Glue Degrader market is projected to reach US$ 649.6 million in 2034, increasing from US$ 365 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Molecular Glue Degrader market research.
Key manufacturers engaged in the Molecular Glue Degrader industry include Proxygen GmbH, BeyondSpring, Life Sensors, Evotec SE, Eli Lilly and Company, Bristol-Myers Squibb Company, C4 Therapeutics, Incyte and Monte Rosa Therapeutics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Molecular Glue Degrader were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Molecular Glue Degrader market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Molecular Glue Degrader market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Proxygen GmbH
BeyondSpring
Life Sensors
Evotec SE
Eli Lilly and Company
Bristol-Myers Squibb Company
C4 Therapeutics
Incyte
Monte Rosa Therapeutics
Segment by Type
Proteolysis Targeting Chimeras (Protags)
Specific and Non-Genetic IAP-Dependent Protein Erasers (Snipers) Target Oriented Protein Degrader Optimizer (TORPEDO)
Lysosomal Targeting Chimeras (Lyttas)
Others
Segment by Application
Cancer Treatment
Infectious Diseases
Genetic Diseases
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Molecular Glue Degrader report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices